Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Asthma
|
1536 | 0.570 | 0.760 | 5 | 132673462 | upstream gene variant | C/T | snv | 0.35 | 0.060 | 1.000 | 6 | 2012 | 2016 | |||||
Allergic rhinitis (disorder)
|
176 | 0.570 | 0.760 | 5 | 132673462 | upstream gene variant | C/T | snv | 0.35 | 0.030 | 0.667 | 3 | 2013 | 2018 | |||||
Multiple Sclerosis
|
1022 | 0.570 | 0.760 | 5 | 132673462 | upstream gene variant | C/T | snv | 0.35 | 0.030 | 0.667 | 3 | 2007 | 2019 | |||||
Breast Carcinoma
|
2793 | 0.570 | 0.760 | 5 | 132673462 | upstream gene variant | C/T | snv | 0.35 | 0.020 | 1.000 | 2 | 2014 | 2017 | |||||
Carcinoma of lung
|
1204 | 0.570 | 0.760 | 5 | 132673462 | upstream gene variant | C/T | snv | 0.35 | 0.020 | 0.500 | 2 | 2015 | 2019 | |||||
Childhood asthma
|
317 | 0.570 | 0.760 | 5 | 132673462 | upstream gene variant | C/T | snv | 0.35 | 0.020 | 1.000 | 2 | 2015 | 2016 | |||||
Graves Disease
|
352 | 0.570 | 0.760 | 5 | 132673462 | upstream gene variant | C/T | snv | 0.35 | 0.020 | 0.500 | 2 | 2011 | 2015 | |||||
Malignant neoplasm of breast
|
3417 | 0.570 | 0.760 | 5 | 132673462 | upstream gene variant | C/T | snv | 0.35 | 0.020 | 1.000 | 2 | 2014 | 2017 | |||||
Malignant neoplasm of lung
|
1142 | 0.570 | 0.760 | 5 | 132673462 | upstream gene variant | C/T | snv | 0.35 | 0.020 | 0.500 | 2 | 2015 | 2019 | |||||
Malignant neoplasm of prostate
|
1082 | 0.570 | 0.760 | 5 | 132673462 | upstream gene variant | C/T | snv | 0.35 | 0.020 | 1.000 | 2 | 2010 | 2017 | |||||
Malignant neoplasm of stomach
|
615 | 0.570 | 0.760 | 5 | 132673462 | upstream gene variant | C/T | snv | 0.35 | 0.020 | 1.000 | 2 | 2017 | 2018 | |||||
Malignant Neoplasms
|
1641 | 0.570 | 0.760 | 5 | 132673462 | upstream gene variant | C/T | snv | 0.35 | 0.020 | 0.500 | 2 | 2013 | 2017 | |||||
Primary malignant neoplasm
|
1374 | 0.570 | 0.760 | 5 | 132673462 | upstream gene variant | C/T | snv | 0.35 | 0.020 | 0.500 | 2 | 2013 | 2017 | |||||
Primary malignant neoplasm of lung
|
981 | 0.570 | 0.760 | 5 | 132673462 | upstream gene variant | C/T | snv | 0.35 | 0.020 | 0.500 | 2 | 2015 | 2019 | |||||
Prostate carcinoma
|
1168 | 0.570 | 0.760 | 5 | 132673462 | upstream gene variant | C/T | snv | 0.35 | 0.020 | 1.000 | 2 | 2010 | 2017 | |||||
Renal Cell Carcinoma
|
288 | 0.570 | 0.760 | 5 | 132673462 | upstream gene variant | C/T | snv | 0.35 | 0.020 | 1.000 | 2 | 2013 | 2017 | |||||
Stomach Carcinoma
|
652 | 0.570 | 0.760 | 5 | 132673462 | upstream gene variant | C/T | snv | 0.35 | 0.020 | 1.000 | 2 | 2017 | 2018 | |||||
Vitamin D Deficiency
|
37 | 0.570 | 0.760 | 5 | 132673462 | upstream gene variant | C/T | snv | 0.35 | 0.020 | 1.000 | 2 | 2011 | 2012 | |||||
Ankylosing spondylitis
|
609 | 0.570 | 0.760 | 5 | 132673462 | upstream gene variant | C/T | snv | 0.35 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Autoimmune Diseases
|
428 | 0.570 | 0.760 | 5 | 132673462 | upstream gene variant | C/T | snv | 0.35 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Brucellosis
|
30 | 0.570 | 0.760 | 5 | 132673462 | upstream gene variant | C/T | snv | 0.35 | 0.010 | 1 | 2020 | 2020 | ||||||
Carcinoma of bladder
|
309 | 0.570 | 0.760 | 5 | 132673462 | upstream gene variant | C/T | snv | 0.35 | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||
CATARACT, ANTERIOR POLAR
|
27 | 0.570 | 0.760 | 5 | 132673462 | upstream gene variant | C/T | snv | 0.35 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Central Diabetes Insipidus
|
21 | 0.570 | 0.760 | 5 | 132673462 | upstream gene variant | C/T | snv | 0.35 | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||
Childhood Leukemia
|
140 | 0.570 | 0.760 | 5 | 132673462 | upstream gene variant | C/T | snv | 0.35 | 0.010 | 1.000 | 1 | 2017 | 2017 |